CC-91633 (BMS-986397)

A Phase 1, Open-label, Dose-finding Study of CC-91633 (BMS-986397) in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes

Arms / Cohorts

Experimental:Part A: Relapsed or Refractory AML and Relapsed or Refractory HR-MDS

Accepting patients

Experimental:Part B: Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

Accepting patients

Experimental:Part B: Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.